Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | GSTP1 | P09211 | 15/20 | 0.47 |
| ▸ | GSTM2 | P28161 | 15/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6123423 | 0.89 | MEN1 (0.51) | MEN1KMT2AGSTP1GSTM2ALDH1A1 | |
| SCHEMBL6510158 | 0.84 | MEN1 (0.49) | MEN1KMT2AGSTP1GSTM2ALDH1A1 | |
| SCHEMBL131795 | 0.83 | MEN1 (0.52) | MEN1KMT2AGSTP1GSTM2KCNH2 | |
| SCHEMBL6951880 | 0.83 | MEN1 (0.52) | MEN1KMT2AGSTP1GSTM2KCNH2 | |
| SCHEMBL14140891 | 0.78 | MEN1 (0.54) | MEN1KMT2AGSTP1GSTM2MAPT | |
| SCHEMBL26054240 | 0.77 | MEN1 (0.56) | MEN1KMT2AGSTP1GSTM2 | |
| SCHEMBL18007677 | 0.77 | KMT2A (0.61) | MEN1KMT2AGSTP1GSTM2HTT | |
| SCHEMBL23612900 | 0.76 | MEN1 (0.52) | MEN1KMT2AGSTP1GSTM2KCNH2 | |
| SCHEMBL3063567 | 0.76 | MEN1 (0.52) | MEN1KMT2AGSTP1GSTM2KCNH2 | |
| SCHEMBL4557847 | 0.76 | GSTP1 (0.44) | MEN1KMT2AGSTP1GSTM2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346641-A1 | COMPOSITIONS AND METHODS FOR THIN FILAMENT MODULATION | UNIV ARIZONA (US) | 2025-11-13 | — | — | US | claimed |
| US-20250341524-A1 | FLUORESCENTLY-LABELED F-ACTIN PROTEIN BIOSENSORS AND METHODS OF HIGH-THROUGHPUT DRUG DISCOVERY | UNIV ARIZONA (US) | 2025-11-06 | — | — | US | claimed |
| US-20240168032-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-23 | — | — | US | claimed |
| EP-3377898-B1 | THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-01 | — | — | EP | claimed |
| EP-3377904-B1 | UREA BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-01 | — | — | EP | claimed |
| EP-3377897-B1 | LACTATE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2024-05-01 | — | — | EP | claimed |
| US-20240019442-A1 | BIOSENSOR FOR DETECTING STRUCTURAL CHANGES IN HUMAN CARDIAC MUSCLE PROTEIN | NATIONAL INSTITUTES OF HEALTH | 2024-01-18 | — | — | US | claimed |
| US-11852637-B2 | Bicarbonate biosensors, calcium biosensors, and uses thereof | DUKE UNIVERSITY (US) | 2023-12-26 | — | — | US | claimed |
| US-20230349911-A1 | COMPOSITIONS AND METHODS TO QUANTIFY THE BINDING INTERACTIONS OF MYOSIN BINDING-PROTEIN C (MYBP-C) | NATIONAL INSTITUTES OF HEALTH | 2023-11-02 | — | — | US | claimed |
| US-20220244266-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | UNIV DUKE (US) | 2022-08-04 | — | — | US | claimed |
| US-7202089-B2 | Detection of stroke in mammals; provide body fluid sample, incubate with fatty acid binding protein and fluorescent agent, measure fluorescence, evaluate for stroke | KLEINFELD ALAN | 2007-04-10 | — | — | US | claimed |
| WO-2006052860-A2 | MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION | SIRION THERAPEUTICS, INC. (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060094063-A1 | Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation | SYTERA, INC. (US) | 2006-05-04 | — | — | US | claimed |
| EP-1424931-A4 | EARLY DIAGNOSIS OF STROKE | KLEINFELD ALAN M (US) | 2004-10-06 | — | — | EP | claimed |
| US-6750030-B2 | MIXING SERUM SAMPLE WITH AQUEOUS SOLUTION AND WITH A REAGENT COMPRISING A FATTY ACID BINDING PROTEIN LABELED WITH A FLUORESCENT MOIETY; MEASURING FLUORESCENCE; DETERMINING CONCENTRATION OF FREE FATTY ACID | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2004-06-15 | — | — | US | claimed |
| EP-1424931-A2 | EARLY DIAGNOSIS OF STROKE | KLEINFELD, Alan M. (US) | 2004-06-09 | — | — | EP | claimed |
| WO-2003024306-A2 | EARLY DIAGNOSIS OF STROKE | KLEINFELD ALAN (US) | 2003-03-27 | — | — | WO | claimed |
| US-20030054412-A1 | Early diagnosis of stroke | KLEINFELD ALAN (US) | 2003-03-20 | — | — | US | claimed |
| US-20020160537-A1 | Mixing serum sample with aqueous solution and with a reagent comprising a fatty acid binding protein labeled with a fluorescent moiety; measuring fluorescence; determining concentration of free fatty acid | KLEINFELD ALAN M (US) | 2002-10-31 | — | — | US | claimed |
| WO-1998057171-A1 | METHOD OF DETECTION OF CARDIAC ISCHEMIA USING FATTY ACID BINDING PROTEIN | MEDICAL BIOLOGY INSTITUTE (US) | 1998-12-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240168032-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | GCK, GCKR, SLC2A4 | MEN1 2391/4885KMT2A 4044/4885GSTP1 688/4885 |
| US-20220244266-A1 | GLUCOSE BIOSENSORS AND USES THEREOF | GCK, GCKR, SLC2A4 | MEN1 2391/4885KMT2A 4044/4885GSTP1 688/4885 |
| US-20060094063-A1 | Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation | RBP1, TTR, RBP4 | MEN1 4500/4885KMT2A 4838/4885GSTP1 3209/4885 |
| US-11852637-B2 | Bicarbonate biosensors, calcium biosensors, and uses thereof | CA2, CASR, CACYBP | MEN1 1448/4885KMT2A 4560/4885GSTP1 2915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.